Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes MellitusYoshihiko Saito, Takeshi Morimoto, Sadanori Okada et al.|Circulation|2016Cited by 141
Low-Dose Aspirin Therapy in Patients With Type 2 Diabetes and Reduced Glomerular Filtration RateYoshihiko Saito, Takeshi Morimoto, Hisao Ogawa et al.|Diabetes Care|2011Cited by 50
Is Long-Term Low-Dose Aspirin Therapy Associated with Renal Dysfunction in Patients with Type 2 Diabetes? JPAD2 Cohort StudySadanori Okada, Takeshi Morimoto, Hisao Ogawa et al.|PLoS ONE|2016Cited by 31
Effect of Aspirin on Cancer Chemoprevention in Japanese Patients With Type 2 Diabetes: 10-Year Observational Follow-up of a Randomized Controlled TrialSadanori Okada, Masanori Kamura, Kazuhiko Yamada et al.|Diabetes Care|2018Cited by 24
Sex Difference in Effects of Low-Dose Aspirin on Prevention of Dementia in Patients With Type 2 Diabetes: A Long-term Follow-up Study of a Randomized Clinical TrialChisa Matsumoto, Masanori Kamura, Hisao Ogawa et al.|Diabetes Care|2019Cited by 21